6
NEWS
IF linked to ED
Intermittent fasting, defined as fasting for more than eight hours at a time,
is a trend that is growing in popularity. Yet new research shows it may be
linked to eating disorder behaviors.
Researchers from the University of Toronto analyzed data from more
than 2700 adolescents and young adults and found that for women,
intermittent fasting was significantly associated with overeating, binge
eating, vomiting, laxative use, and compulsive exercise.
Study investigator Kyle Ganson, PhD, told Medscape Medical News that
evidence on the effectiveness of IF for weight loss and disease prevention
is mixed, and that it is important to understand the potential harms of
intermittent fasting - even if there are benefits for some: "If anything,
this study shines light on the fact that engagement in Intermittent fasting
may be connected with problematic eating disorder behaviors, requiring
healthcare professionals to be very aware of this contemporary and popular
dietary trend, despite proponents on social media touting the effectiveness
and benefits."
Sheffield Diabetes Tech event
Diabetes UK Sheffield are holding a big event about Diabetes and Tech on
Saturday May 13th; speakers include Nerdabetic, Kamil Armacki, Diabetech's
Tim Street, and the clinician and academic Professor Emma Wilmot. The event
is sponsored by Glooko, Abbott, Dexcom and Medtrum, all of whom will have
stands give presentations, and participation by other diabetes tech companies
are also planned in order to increase knowledge and awareness of tech.
For more information and to register, CLICK HERE
CE Mark for
DOSE
Innovation Zed has announced that
it has secured a CE Mark for its
InsulCheck DOSE add-on device.
InsulCheck DOSE is a singleunit
add-on device compatible with
all pen injectors that automatically
captures the dose value dialled, the
time of the injection, the temperature
and other data. This is logged and
sent automatically to a compatible
display device.
Dr Dean Minnock, CEO of
Innovation Zed, said, "InsulCheck
DOSE provides data that, when
applied correctly, facilitates an
evidence-driven approach to
precision insulin management and
significantly helps people with
diabetes make more informed
choices for their personal therapy
plan. Our InsulCheck DOSE supports
all insulin pens without changing the
usability of the pen in any way and
without interfering in the normal
injection process. In securing the
CE mark for InsulCheck DOSE we
reached an incredible milestone for
our company and for people living
with diabetes in Europe."
Innovation Zed expects to initiate
a commercial launch of InsulCheck
DOSE in Europe during 2023. The
company also has plans to introduce
bespoke variations of InsulCheck
DOSE to new injection devices for
various drug therapies over the
coming years.
mylife Loop
remote follow
Parents and caregivers of children
with diabetes can now follow their
child's glucose and insulin data via
the mylife CamAPS FX app on their
own personal smartphone.
The new 'Companion remote
monitoring' feature is fully integrated
into the app, giving parents and
caregivers a view of all their child's
therapy data at any time via their
smartphone - regardless of whether
the child is at school, enjoying his or
her hobbies or meeting friends - and
especially at night. Besides a display
of Continuous Glucose Monitoring
(CGM) data, the app also provides
insulin delivery data, Boost & EaseOff
usage, pump information and
other relevant mylife CamAPS FX
information.
The mylife YpsoPump and mylife
CamAPS FX is the only automated
insulin delivery (AID) system that
can be connected either to the
Dexcom G6 sensor from Dexcom
or to the FreeStyle Libre 3 sensor
from Abbott. The latter has been
compatible with mylife Loop in
Germany since December 2022 and
this compatibility will be rolled out in
Switzerland, UK and the Netherlands
in the first half of 2023. The mylife
Loop offer is currently available for
Android; iOS will follow.